2024. Targeting Alpha-Synuclein as a Treatment for Parkinson’s Disease . International Journal of Pharmaceutical and Healthcare Innovation. 1, 04 (Aug. 2024), 296–307. DOI:https://doi.org/10.62752/9v9h6s45.